The company MEDICSKIN (08307) has announced its financial projections. The group anticipates reporting an annual comprehensive profit attributable to its owners in the range of approximately HK$500,000 to HK$1.5 million for the fiscal year ending March 31, 2026.

This forecast represents a significant improvement compared to the same period in the previous year, which saw a net loss attributable to owners of about HK$3.4 million.

The board of directors attributes this positive shift from a loss to a profit primarily to two key factors. The first contributing element is a year-on-year increase in the group's revenue for the period ending March 31, 2026.

This revenue growth is credited to an expansion in the number of clients utilizing its treatment services and a rise in the frequency of client visits for these services.

The second major factor is the achievement of cost savings across several areas. These savings include a reduction in rental expenses, which consequently lowered the depreciation of right-of-use assets, and a decrease in overall employee-related costs.